批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/10/30 |
SUPPL-100(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/11/02 |
SUPPL-97(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/12/22 |
SUPPL-95(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2017/12/22 |
SUPPL-90(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/03/17 |
SUPPL-91(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2015/03/03 |
SUPPL-89(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2013/12/26 |
SUPPL-88(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2013/10/29 |
SUPPL-79(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2013/07/22 |
SUPPL-87(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2013/06/11 |
SUPPL-76(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2013/04/09 |
SUPPL-78(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2013/03/28 |
SUPPL-84(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/02/20 |
SUPPL-86(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2013/02/16 |
SUPPL-83(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2013/02/13 |
SUPPL-85(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2010/02/19 |
SUPPL-74(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2002/07/17 |
SUPPL-66(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2000/12/14 |
SUPPL-64(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2000/12/08 |
SUPPL-65(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1999/05/26 |
SUPPL-61(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1998/03/06 |
SUPPL-62(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1997/12/08 |
SUPPL-57(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1996/05/31 |
SUPPL-59(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1996/05/02 |
SUPPL-60(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1996/01/03 |
SUPPL-58(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1995/07/18 |
SUPPL-56(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1995/07/11 |
SUPPL-55(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1994/11/21 |
SUPPL-54(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1993/10/20 |
SUPPL-51(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1993/04/13 |
SUPPL-53(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1993/02/18 |
SUPPL-52(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1991/03/21 |
SUPPL-36(补充) |
Approval |
Labeling |
|
|
|
1991/03/21 |
SUPPL-35(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1990/10/02 |
SUPPL-50(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1989/07/11 |
SUPPL-49(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1988/12/02 |
SUPPL-48(补充) |
Approval |
Labeling |
|
|
|
1988/12/02 |
SUPPL-47(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1987/09/16 |
SUPPL-43(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1987/09/11 |
SUPPL-46(补充) |
Approval |
Labeling |
|
|
|
1987/09/11 |
SUPPL-45(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1987/03/18 |
SUPPL-44(补充) |
Approval |
Labeling |
|
|
|
1986/11/13 |
SUPPL-38(补充) |
Approval |
Labeling |
|
|
|
1986/11/13 |
SUPPL-37(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1986/08/29 |
SUPPL-40(补充) |
Approval |
Labeling |
|
|
|
1986/08/29 |
SUPPL-39(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1986/05/19 |
SUPPL-42(补充) |
Approval |
Labeling |
|
|
|
1986/02/27 |
SUPPL-41(补充) |
Approval |
Labeling |
|
|
|
1986/02/22 |
SUPPL-29(补充) |
Approval |
Labeling |
|
|
|
1986/02/22 |
SUPPL-28(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1985/03/22 |
SUPPL-34(补充) |
Approval |
Labeling |
|
|
|
1985/03/22 |
SUPPL-33(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1984/12/12 |
SUPPL-27(补充) |
Approval |
Labeling |
|
|
|
1984/12/03 |
SUPPL-32(补充) |
Approval |
Labeling |
|
|
|
1982/07/26 |
SUPPL-25(补充) |
Approval |
Labeling |
|
|
|
1982/07/26 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1982/06/28 |
SUPPL-31(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1982/03/25 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1981/10/01 |
SUPPL-26(补充) |
Approval |
Labeling |
|
|
|
1981/10/01 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1980/12/31 |
SUPPL-20(补充) |
Approval |
Labeling |
|
|
|
1980/04/17 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1979/08/29 |
SUPPL-21(补充) |
Approval |
Labeling |
|
|
|
1979/04/09 |
SUPPL-18(补充) |
Approval |
Labeling |
|
|
|
1979/04/09 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1979/03/26 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1979/02/27 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1978/05/17 |
SUPPL-15(补充) |
Approval |
Labeling |
|
|
|
1976/02/02 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1975/10/09 |
SUPPL-11(补充) |
Approval |
Labeling |
|
|
|
1975/08/28 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1975/08/28 |
SUPPL-8(补充) |
Approval |
Labeling |
|
|
|
1975/07/16 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1974/06/24 |
SUPPL-6(补充) |
Approval |
Supplement |
|
|
|
1974/05/20 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1972/12/04 |
SUPPL-2(补充) |
Approval |
Labeling |
|
|
|
1948/11/19 |
ORIG-1(原始申请) |
Approval |
|
UNKNOWN
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:LIDOCAINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:2% 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
006488 |
002 |
NDA |
XYLOCAINE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
017584 |
001 |
NDA |
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
080407 |
002 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
Approved Prior to Jan 1, 1982
|
WEST-WARD PHARMS INT |
083158 |
002 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
083173 |
002 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
Approved Prior to Jan 1, 1982
|
INTL MEDICATION |
084625 |
002 |
ANDA |
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
Approved Prior to Jan 1, 1982
|
HIKMA |
088586 |
003 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
088294 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
1984/05/17
|
HOSPIRA |
088327 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
1984/07/31
|
HOSPIRA |
040078 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
1995/06/23
|
HOSPIRA |
040302 |
002 |
ANDA |
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
1998/09/28
|
HOSPIRA |
203040 |
002 |
ANDA |
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
2013/03/14
|
EUGIA PHARMA |
203082 |
002 |
ANDA |
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
2013/03/14
|
EUGIA PHARMA |
207182 |
002 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
2017/10/30
|
EUGIA PHARMA |
214339 |
002 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
2021/11/08
|
ASPIRO |
214267 |
002 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
2022/09/19
|
SINTETICA US |
212821 |
002 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
2023/06/15
|
HUONS |
217692 |
002 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
2023/06/16
|
MANKIND PHARMA |
217693 |
002 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
2023/07/11
|
MANKIND PHARMA |
214336 |
002 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
2% |
Prescription |
No |
No |
AP |
2023/12/13
|
ASPIRO |
活性成分:EPINEPHRINE; LIDOCAINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.01MG/ML;1% 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
006488 |
004 |
NDA |
XYLOCAINE W/ EPINEPHRINE |
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.01MG/ML;1% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
089644 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE |
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.01MG/ML;1% |
Prescription |
No |
No |
AP |
1988/06/21
|
HOSPIRA |
活性成分:EPINEPHRINE; LIDOCAINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.02MG/ML;2% 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
006488 |
005 |
NDA |
XYLOCAINE W/ EPINEPHRINE |
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.02MG/ML;2% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
活性成分:LIDOCAINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:1% 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
080407 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
Approved Prior to Jan 1, 1982
|
WEST-WARD PHARMS INT |
080408 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
083158 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
083173 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
Yes |
No |
AP |
Approved Prior to Jan 1, 1982
|
INTL MEDICATION |
084625 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
Approved Prior to Jan 1, 1982
|
HIKMA |
006488 |
007 |
NDA |
XYLOCAINE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
088586 |
002 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
088329 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
1984/05/17
|
HOSPIRA |
088299 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
1984/07/31
|
HOSPIRA |
088586 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
1985/07/24
|
FRESENIUS KABI USA |
040302 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
1998/09/28
|
HOSPIRA |
203040 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
2013/03/14
|
EUGIA PHARMA |
203082 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
2013/03/14
|
EUGIA PHARMA |
207182 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
2017/10/30
|
EUGIA PHARMA |
208017 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
2018/04/18
|
SPECTRA MDCL DEVICES |
208474 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
2018/08/03
|
B BRAUN MEDICAL INC |
212821 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
2020/05/07
|
HUONS |
214336 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
2021/11/08
|
ASPIRO |
214339 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
2021/11/08
|
ASPIRO |
215132 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
2022/06/09
|
AFAXYS |
214267 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
2022/09/19
|
SINTETICA US |
217692 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
2023/06/16
|
MANKIND PHARMA |
217693 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
2023/07/11
|
MANKIND PHARMA |
217692 |
003 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1% |
Prescription |
No |
No |
AP |
2023/11/29
|
MANKIND PHARMA |
活性成分:LIDOCAINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.5% 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
006488 |
008 |
NDA |
XYLOCAINE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
088328 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
1984/05/17
|
HOSPIRA |
088325 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.5% |
Prescription |
No |
No |
AP |
1984/07/31
|
HOSPIRA |
活性成分:LIDOCAINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:1.5% 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
006488 |
010 |
NDA |
XYLOCAINE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1.5% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
080408 |
002 |
ANDA |
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE |
LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
1.5% |
Prescription |
No |
No |
AP |
Approved Prior to Jan 1, 1982
|
HOSPIRA |
活性成分:EPINEPHRINE; LIDOCAINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.005MG/ML;0.5% 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
006488 |
012 |
NDA |
XYLOCAINE W/ EPINEPHRINE |
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.005MG/ML;0.5% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
089635 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE |
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.005MG/ML;0.5% |
Prescription |
No |
No |
AP |
1988/06/21
|
HOSPIRA |
活性成分:EPINEPHRINE; LIDOCAINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.005MG/ML;1.5% 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
006488 |
017 |
NDA |
XYLOCAINE W/ EPINEPHRINE |
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.005MG/ML;1.5% |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
088571 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE |
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.005MG/ML;1.5% |
Prescription |
No |
No |
AP |
1985/09/13
|
HOSPIRA |
089645 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE |
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.005MG/ML;1.5% |
Prescription |
No |
No |
AP |
1988/06/21
|
HOSPIRA |
208475 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE |
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.005MG/ML;1.5% |
Prescription |
No |
No |
AP |
2021/09/08
|
B BRAUN MEDICAL INC |
活性成分:EPINEPHRINE; LIDOCAINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.005MG/ML;2% 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
006488 |
019 |
NDA |
XYLOCAINE W/ EPINEPHRINE |
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.005MG/ML;2% |
Prescription |
Yes |
Yes |
AP |
1986/11/13
|
FRESENIUS KABI USA |
089651 |
001 |
ANDA |
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE |
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
0.005MG/ML;2% |
Prescription |
No |
No |
AP |
1988/06/21
|
HOSPIRA |